Celcuity (CELC) Cash & Equivalents (2016 - 2026)
Celcuity's Cash & Equivalents came in at $182.05 million for Q2 2026, up 292.7% from $46.35 million a year earlier.
Powered by 
Analysis
Celcuity (CELC) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Celcuity's Cash & Equivalents was $165.7 million, up 636.0% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 70.1% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $22.52 million in FY2024 (-26.6%), $30.66 million in FY2023 (+24.8%), $24.57 million in FY2022 (-70.8%) and $84.29 million in FY2021 (+624.2%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents in data going back to Q3 2016.
- Year-over-year, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 192.2%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2025 (growth of 636.0%), and the weakest in Q4 2022 (a decline of 70.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Celcuity | 3.89 Bn | 3.89 Bn | - | 182.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182.05 Mn |
| Dec 31, 2025 | 165.70 Mn |
| Sep 30, 2025 | 74.25 Mn |
| Jun 30, 2025 | 46.35 Mn |
| Mar 31, 2025 | 16.48 Mn |
| Dec 31, 2024 | 22.52 Mn |
| Sep 30, 2024 | 12.60 Mn |
| Jun 30, 2024 | 30.46 Mn |
| Mar 31, 2024 | 31.21 Mn |
| Dec 31, 2023 | 30.66 Mn |
| Sep 30, 2023 | 25.76 Mn |
| Jun 30, 2023 | 32.24 Mn |
| Mar 31, 2023 | 33.64 Mn |
| Dec 31, 2022 | 24.57 Mn |
| Sep 30, 2022 | 57.48 Mn |
| Jun 30, 2022 | 66.91 Mn |
| Mar 31, 2022 | 78.30 Mn |
| Dec 31, 2021 | 84.29 Mn |
| Sep 30, 2021 | 90.37 Mn |
| Jun 30, 2021 | 41.64 Mn |
API Access
Celcuity Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CELC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CELC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CELC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();